Module 3: Disease-modifying Therapies in MCI and Early AD

Primary Audience:

This activity is intended to meet the educational needs a multidisciplinary group of care providers involved in the diagnosis and management of AD, including neurologists, dementia specialists, geriatricians, geriatric psychologists, radiologists, and primary care clinicians.

Relevant Terms:

Alzheimer's disease, dementia

The focus of this module will be on monoclonal antibodies emerging and approved for use in treating early AD.

Muhammad Haroon Burhanullah, MD

Assistant Professor of Psychiatry and Behavioral Sciences
Psychiatry and Behaviorial Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr. M. Haroon Burhanullah is a board-certified psychiatrist with experience in consultation psychiatry, emergency psychiatry, and geriatric neuropsychiatry. He graduated from Dow Medical College in Pakistan before completing postdoctoral work in neuroimaging at Johns Hopkins University. Dr. Burhanullah was a fellow in geriatric psychiatry at Johns Hopkins and did his psychiatric residency at Bergen Regional Medical Center, where he graduated as Executive Chief Resident. He has done clinical research on mood and memory disorders and Alzheimer's disease. While at Bergen, Dr. Burhanullah was awarded the American Psychiatric Association’s Resident’s Recognition Award and was elected President of the Resident’s Chapter of the New Jersey Psychiatry Association. He has published in several peer-reviewed journals, including the highly respected American Journal of Geriatric Psychiatry. He serves on the International Alzheimer’s Association executive committee and is the president of the Association of Physicians of Pakistani Descent, Maryland Chapter. Dr. Burhanullah is deeply committed to treating patients with complicated medical and neurological illnesses, such as Alzheimer’s disease, Lewy Body disease, and traumatic brain injuries. He is passionate about working with the most vulnerable patients, including those with moderate to severe behavioral problems whose families often suffer from caregiver burnout. Another cornerstone of Dr. Burhanullah’s professional practice is his experience in telepsych, which he deems valuable for the access and ease it provides to both doctors and patients. Though telepsych appointments are remote - he believes they can be just as beneficial as meeting in person.

Apply recently published clinical data to management strategies for adults with MCI and early AD.